Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2013

Open Access 01-12-2013 | Research

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening

Authors: Alberto López-Lera, Fátima Sánchez Cabo, Sofía Garrido, Ana Dopazo, Margarita López-Trascasa

Published in: Orphanet Journal of Rare Diseases | Issue 1/2013

Login to get access

Abstract

Background

Hereditary Angioedema due to C1-Inhibitor deficiency (HAE types I and II) is a monogenic disease characterized by sudden, self-limited episodes of cutaneous and mucosal swelling due to local deregulation of vascular permeability. Despite its monogenic pattern of inheritance, HAE exhibits great clinical variability and low genotype/phenotype correlation among those affected, which ultimately hinders therapeutic approach and probably underlies yet unknown genetic and environmental factors.

Methods

We studied whole-genome RNA expression of PBMCs in three HAE type-I families (accounting for 40 individuals), 24 of which carry the same R472X mutation in the C1-Inhibitor gene and show large variability in terms of disease expression. Those included in this study were analyzed according to the presence of mutation and/or clinical symptoms.

Results

Instead of a single, common disease-associated expression pattern, we found different transcriptome signatures in two of the families studied. In one of them (referred to as DR family), symptoms correlate with the upregulation of 35 genes associated to the biological response to viral infections (including RSADs, OAS, MX and ISG pathway members) and immune response. In another pedigree (Q family), disease manifestation is linked to the upregulation of 43 genes with diverse functions, including transcription and protein folding. Moreover, symptoms-free members of the Q pedigree display relatively higher expression of 394 genes with a wide diversity of functions.

Conclusion

We found no evidence for a common altered PBMC expression pattern linked to HAE symptoms in the three families analyzed. All the data considered, differential gene expression in PBMCs do not seem to play a significant role in the predisposition or protection against HAE in the basal -between crises- conditions analyzed. Although the RNA expression pattern associated to the response to viral infections observed in the DR family supports the idea of infectious diseases as a modifying factor for HAE severity, large-scale studies would be needed to statistically associate such expression pattern to the development of this rare disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, Gómez-Traseira C, González-Quevedo T, Guilarte M, Jurado-Palomo J, Larco JI, López-Serrano MC, López-Trascasa M, Marcos C, Muñoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A, Spanish Study Group on Bradykinin-Induced Angioedema (SGBA): Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011, 21 (5): 333-347.PubMed Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, Gómez-Traseira C, González-Quevedo T, Guilarte M, Jurado-Palomo J, Larco JI, López-Serrano MC, López-Trascasa M, Marcos C, Muñoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A, Spanish Study Group on Bradykinin-Induced Angioedema (SGBA): Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011, 21 (5): 333-347.PubMed
2.
go back to reference Cichon S, Martin L, Hennies HC, Müller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renné T, Drouet C, Bork K, Nöthen MM: Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet. 2006, 79 (6): 1098-1104. 10.1086/509899.PubMedCentralPubMedCrossRef Cichon S, Martin L, Hennies HC, Müller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renné T, Drouet C, Bork K, Nöthen MM: Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet. 2006, 79 (6): 1098-1104. 10.1086/509899.PubMedCentralPubMedCrossRef
3.
go back to reference Bossi F, Peerschke EI, Ghebrehiwet B, Tedesco F: Cross-talk between the complement and the kinin system in vascular permeability. Immunol Lett. 2011, 140 (1–2): 7-13.PubMedCentralPubMedCrossRef Bossi F, Peerschke EI, Ghebrehiwet B, Tedesco F: Cross-talk between the complement and the kinin system in vascular permeability. Immunol Lett. 2011, 140 (1–2): 7-13.PubMedCentralPubMedCrossRef
4.
go back to reference Joseph K, Tuscano TB, Kaplan AP: Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. 2008, 101 (3): 279-286. 10.1016/S1081-1206(10)60493-0.PubMedCrossRef Joseph K, Tuscano TB, Kaplan AP: Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. 2008, 101 (3): 279-286. 10.1016/S1081-1206(10)60493-0.PubMedCrossRef
5.
go back to reference Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A: Plasma bradykinin in angio-oedema. Lancet. 1998, 351 (9117): 1693-1697. 10.1016/S0140-6736(97)09137-X.PubMedCrossRef Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A: Plasma bradykinin in angio-oedema. Lancet. 1998, 351 (9117): 1693-1697. 10.1016/S0140-6736(97)09137-X.PubMedCrossRef
6.
go back to reference Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Németh E, Nielsen EW, Nuijens JH, O’grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Späth PJ, Szendei G, Takács E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004, 114 (3 Suppl): S51-S131.PubMedCrossRef Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Németh E, Nielsen EW, Nuijens JH, O’grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Späth PJ, Szendei G, Takács E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004, 114 (3 Suppl): S51-S131.PubMedCrossRef
7.
go back to reference Cillari E, Misiano G, Aricò M, La Rocca E, Lio D, di Leonardo S, Brai M: Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Am J Clin Pathol. 1986, 85 (3): 305-311.PubMed Cillari E, Misiano G, Aricò M, La Rocca E, Lio D, di Leonardo S, Brai M: Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Am J Clin Pathol. 1986, 85 (3): 305-311.PubMed
8.
go back to reference Brickman CM, Tsokos GC, Chused TM, Balow JE, Lawley TJ, Santaella M, Hammer CH, Linton GF, Frank MM: Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. J Allergy Clin Immunol. 1986, 77 (5): 758-767. 10.1016/0091-6749(86)90425-2.PubMedCrossRef Brickman CM, Tsokos GC, Chused TM, Balow JE, Lawley TJ, Santaella M, Hammer CH, Linton GF, Frank MM: Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. J Allergy Clin Immunol. 1986, 77 (5): 758-767. 10.1016/0091-6749(86)90425-2.PubMedCrossRef
9.
go back to reference Gelfand JA, Sherins RJ, Alling DW, Frank MM: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976, 295 (26): 1444-1448. 10.1056/NEJM197612232952602.PubMedCrossRef Gelfand JA, Sherins RJ, Alling DW, Frank MM: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976, 295 (26): 1444-1448. 10.1056/NEJM197612232952602.PubMedCrossRef
10.
go back to reference Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003, 19 (2): 185-193. 10.1093/bioinformatics/19.2.185.PubMedCrossRef Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003, 19 (2): 185-193. 10.1093/bioinformatics/19.2.185.PubMedCrossRef
11.
go back to reference Vasekar M, Craig TJ: ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep. 2012, 12 (1): 72-78. 10.1007/s11882-011-0238-z.PubMedCrossRef Vasekar M, Craig TJ: ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep. 2012, 12 (1): 72-78. 10.1007/s11882-011-0238-z.PubMedCrossRef
12.
go back to reference Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reise Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006, 441 (7089): 101-105. 10.1038/nature04734.PubMedCrossRef Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reise Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006, 441 (7089): 101-105. 10.1038/nature04734.PubMedCrossRef
13.
go back to reference Co JG, Witwer KW, Gama L, Zink MC, Clements JE: Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J Infect Dis. 2011, 204 (7): 1104-1114. 10.1093/infdis/jir469.PubMedCentralPubMedCrossRef Co JG, Witwer KW, Gama L, Zink MC, Clements JE: Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J Infect Dis. 2011, 204 (7): 1104-1114. 10.1093/infdis/jir469.PubMedCentralPubMedCrossRef
14.
go back to reference Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW: Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res. 2001, 2 (2): 71-79. 10.1186/rr41. ReviewPubMedCentralPubMedCrossRef Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW: Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res. 2001, 2 (2): 71-79. 10.1186/rr41. ReviewPubMedCentralPubMedCrossRef
15.
go back to reference Mukaida N: Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 2003, 284 (4): L566-L577. ReviewPubMedCrossRef Mukaida N: Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 2003, 284 (4): L566-L577. ReviewPubMedCrossRef
16.
go back to reference Li H, Richardson WD: The evolution of Olig genes and their roles in myelination. Neuron Glia Biol. 2008, 4 (2): 129-135. 10.1017/S1740925X09990251.PubMedCrossRef Li H, Richardson WD: The evolution of Olig genes and their roles in myelination. Neuron Glia Biol. 2008, 4 (2): 129-135. 10.1017/S1740925X09990251.PubMedCrossRef
17.
go back to reference Spellman R, Rideau A, Matlin A, Gooding C, Robinson F, McGlincy N, Grellscheid SN, Southby J, Wollerton M, Smith CW: Regulation of alternative splicing by PTB and associated factors. Biochem Soc Trans. 2005, 33 (Pt 3): 457-460.PubMedCrossRef Spellman R, Rideau A, Matlin A, Gooding C, Robinson F, McGlincy N, Grellscheid SN, Southby J, Wollerton M, Smith CW: Regulation of alternative splicing by PTB and associated factors. Biochem Soc Trans. 2005, 33 (Pt 3): 457-460.PubMedCrossRef
18.
go back to reference Freiberger T, Grombiříková H, Ravčuková B, Jarkovský J, Kuklínek P, Kryštůfková O, Hanzlíková J, Daňková E, Kopecký O, Zachová R, Lahodná M, Vašáková M, Grodecká L, Litzman J: No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Scand J Immunol. 2011, 74 (1): 100-106. 10.1111/j.1365-3083.2011.02547.x.PubMedCrossRef Freiberger T, Grombiříková H, Ravčuková B, Jarkovský J, Kuklínek P, Kryštůfková O, Hanzlíková J, Daňková E, Kopecký O, Zachová R, Lahodná M, Vašáková M, Grodecká L, Litzman J: No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Scand J Immunol. 2011, 74 (1): 100-106. 10.1111/j.1365-3083.2011.02547.x.PubMedCrossRef
19.
go back to reference Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D, Saint-Onge J, Flury L, Brown NJ, Gainer JV, Rouleau JL, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, Wehbe B, Benarbia S, Marc-Aurele J, Chanard J, Foroud T, Adam A, Rouleau GA: A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet. 2005, 77 (4): 617-626. 10.1086/496899.PubMedCentralPubMedCrossRef Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D, Saint-Onge J, Flury L, Brown NJ, Gainer JV, Rouleau JL, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, Wehbe B, Benarbia S, Marc-Aurele J, Chanard J, Foroud T, Adam A, Rouleau GA: A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet. 2005, 77 (4): 617-626. 10.1086/496899.PubMedCentralPubMedCrossRef
20.
go back to reference Klausegger A, Wiednig M, Urban C, Lackner H, Reiter H, Bauer JW, Aberer W: Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect. Bone Marrow Transplant. 2012, 47 (9): 1259-1261. 10.1038/bmt.2012.7.PubMedCrossRef Klausegger A, Wiednig M, Urban C, Lackner H, Reiter H, Bauer JW, Aberer W: Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect. Bone Marrow Transplant. 2012, 47 (9): 1259-1261. 10.1038/bmt.2012.7.PubMedCrossRef
21.
go back to reference Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM: Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J Allergy Clin Immunol. 1986, 77 (5): 749-757. 10.1016/0091-6749(86)90424-0.PubMedCrossRef Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM: Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J Allergy Clin Immunol. 1986, 77 (5): 749-757. 10.1016/0091-6749(86)90424-0.PubMedCrossRef
22.
go back to reference Farkas H, Csuka D, Gács J, Czaller I, Zotter Z, Füst G, Varga L, Gergely P: Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. Clin Immunol. 2011, 141 (1): 58-66. 10.1016/j.clim.2011.05.004. Epub 2011PubMedCrossRef Farkas H, Csuka D, Gács J, Czaller I, Zotter Z, Füst G, Varga L, Gergely P: Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. Clin Immunol. 2011, 141 (1): 58-66. 10.1016/j.clim.2011.05.004. Epub 2011PubMedCrossRef
23.
go back to reference Kessel A, Peri R, Perricone R, Guarino MD, Vadasz Z, Novak R, Haj T, Kivity S, Toubi E: The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency. Clin Exp Immunol. 2012, 167 (3): 422-428. 10.1111/j.1365-2249.2011.04527.x.PubMedCentralPubMedCrossRef Kessel A, Peri R, Perricone R, Guarino MD, Vadasz Z, Novak R, Haj T, Kivity S, Toubi E: The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency. Clin Exp Immunol. 2012, 167 (3): 422-428. 10.1111/j.1365-2249.2011.04527.x.PubMedCentralPubMedCrossRef
24.
go back to reference Cedzyński M, Madaliński K, Gregorek H, Swierzko AS, Nowicka E, Obtułowicz K, Dzierzanowska-Fangrat K, Wojda U, Rabczenko D, Kawakami M: Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults. Arch Immunol Ther Exp (Warsz). 2008, 56 (1): 69-75. 10.1007/s00005-008-0004-7.CrossRef Cedzyński M, Madaliński K, Gregorek H, Swierzko AS, Nowicka E, Obtułowicz K, Dzierzanowska-Fangrat K, Wojda U, Rabczenko D, Kawakami M: Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults. Arch Immunol Ther Exp (Warsz). 2008, 56 (1): 69-75. 10.1007/s00005-008-0004-7.CrossRef
25.
go back to reference Farkas H, Gyeney L, Majthényi P, Füst G, Varga L: Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol. 1999, 37 (6): 513-518.PubMed Farkas H, Gyeney L, Majthényi P, Füst G, Varga L: Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol. 1999, 37 (6): 513-518.PubMed
26.
go back to reference Farkas H, Füst G, Fekete B, Karádi I, Varga L: Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet. 2001, 358 (9294): 1695-1696. 10.1016/S0140-6736(01)06720-4.PubMedCrossRef Farkas H, Füst G, Fekete B, Karádi I, Varga L: Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet. 2001, 358 (9294): 1695-1696. 10.1016/S0140-6736(01)06720-4.PubMedCrossRef
27.
go back to reference Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976, 84 (5): 580-593. 10.7326/0003-4819-84-5-580.PubMedCrossRef Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976, 84 (5): 580-593. 10.7326/0003-4819-84-5-580.PubMedCrossRef
Metadata
Title
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening
Authors
Alberto López-Lera
Fátima Sánchez Cabo
Sofía Garrido
Ana Dopazo
Margarita López-Trascasa
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2013
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-8-77

Other articles of this Issue 1/2013

Orphanet Journal of Rare Diseases 1/2013 Go to the issue